Back

Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials

European Journal of Preventive Cardiology

8 August 2022
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.
29 June 2021
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025
thumbnail
Congress Presentation
Addition of sodium-glucose cotransporter-2 inhibitors on steroidal mineralocorticoid receptor antagonists eliminates hyperkalemia risk in diabetic heart failure patients with chronic kidney disease
17 May 2025
thumbnail
Congress Presentation
Comparative effectiveness of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a comprehensive Bayesian network meta-analysis with intervention ranking
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources